Pronova Biopharma ASA
BASF AS has successfully completed the voluntary
offer for Pronova BioPharma ASA, Lysaker, Norway,
[OBX: PRON], which closed today with the payment of
the offer price to Pronova shareholders. At the same
time, 295 374 009 tendered shares were transferred to
BASF AS. BASF AS now holds 295 374 009 shares in
Pronova BioPharma ASA, equalling 98.19% of the issued
shares and votes of Pronova BioPharma ASA.
BASF AS intends to effect a compulsory acquisition
(squeeze-out) of all issued shares of Pronova
BioPharma ASA that are not currently owned by BASF AS
(the "Minority Shares"), in accordance with the
Norwegian Public Limited Liability Companies Act
section 4-25 and the Norwegian Securities Trading Act
section 6-22 as soon as possible.